Logo image of BRNL.AS

BRUNEL INTERNATIONAL (BRNL.AS) Stock Fundamental Analysis

Europe - AMS:BRNL - NL0010776944 - Common Stock

7.96 EUR
-0.04 (-0.5%)
Last: 10/24/2025, 11:57:17 AM
Fundamental Rating

6

Taking everything into account, BRNL scores 6 out of 10 in our fundamental rating. BRNL was compared to 32 industry peers in the Professional Services industry. BRNL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BRNL is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BRNL had positive earnings in the past year.
BRNL had a positive operating cash flow in the past year.
BRNL had positive earnings in each of the past 5 years.
Each year in the past 5 years BRNL had a positive operating cash flow.
BRNL.AS Yearly Net Income VS EBIT VS OCF VS FCFBRNL.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

BRNL has a Return On Assets (2.79%) which is comparable to the rest of the industry.
The Return On Equity of BRNL (5.63%) is worse than 62.50% of its industry peers.
BRNL has a Return On Invested Capital (5.99%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for BRNL is below the industry average of 11.46%.
Industry RankSector Rank
ROA 2.79%
ROE 5.63%
ROIC 5.99%
ROA(3y)5.23%
ROA(5y)5.1%
ROE(3y)9.87%
ROE(5y)9.22%
ROIC(3y)9.07%
ROIC(5y)8.49%
BRNL.AS Yearly ROA, ROE, ROICBRNL.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of BRNL (1.19%) is worse than 65.63% of its industry peers.
BRNL's Profit Margin has improved in the last couple of years.
The Operating Margin of BRNL (2.77%) is comparable to the rest of the industry.
BRNL's Operating Margin has improved in the last couple of years.
The Gross Margin of BRNL (18.53%) is worse than 78.13% of its industry peers.
In the last couple of years the Gross Margin of BRNL has remained more or less at the same level.
Industry RankSector Rank
OM 2.77%
PM (TTM) 1.19%
GM 18.53%
OM growth 3Y-10.31%
OM growth 5Y16.91%
PM growth 3Y-14.07%
PM growth 5Y42.87%
GM growth 3Y-6.27%
GM growth 5Y-0.85%
BRNL.AS Yearly Profit, Operating, Gross MarginsBRNL.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRNL is still creating some value.
The number of shares outstanding for BRNL remains at a similar level compared to 1 year ago.
The number of shares outstanding for BRNL has been reduced compared to 5 years ago.
BRNL has a better debt/assets ratio than last year.
BRNL.AS Yearly Shares OutstandingBRNL.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BRNL.AS Yearly Total Debt VS Total AssetsBRNL.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.50 indicates that BRNL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.50, BRNL belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
The Debt to FCF ratio of BRNL is 1.94, which is an excellent value as it means it would take BRNL, only 1.94 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BRNL (1.94) is better than 93.75% of its industry peers.
A Debt/Equity ratio of 0.40 indicates that BRNL is not too dependend on debt financing.
BRNL has a Debt to Equity ratio of 0.40. This is in the better half of the industry: BRNL outperforms 65.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 1.94
Altman-Z 4.5
ROIC/WACC0.9
WACC6.67%
BRNL.AS Yearly LT Debt VS Equity VS FCFBRNL.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

BRNL has a Current Ratio of 2.71. This indicates that BRNL is financially healthy and has no problem in meeting its short term obligations.
BRNL has a better Current ratio (2.71) than 96.88% of its industry peers.
A Quick Ratio of 2.71 indicates that BRNL has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.71, BRNL belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 2.71
BRNL.AS Yearly Current Assets VS Current LiabilitesBRNL.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

BRNL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.46%.
BRNL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 50.91% yearly.
Looking at the last year, BRNL shows a decrease in Revenue. The Revenue has decreased by -6.90% in the last year.
The Revenue has been growing slightly by 5.56% on average over the past years.
EPS 1Y (TTM)-50.46%
EPS 3Y-1.22%
EPS 5Y50.91%
EPS Q2Q%-97.98%
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y14.9%
Revenue growth 5Y5.56%
Sales Q2Q%-11.33%

3.2 Future

The Earnings Per Share is expected to grow by 6.75% on average over the next years.
The Revenue is expected to grow by 2.40% on average over the next years.
EPS Next Y-27.98%
EPS Next 2Y2.29%
EPS Next 3Y6.75%
EPS Next 5YN/A
Revenue Next Year-6.3%
Revenue Next 2Y-0.35%
Revenue Next 3Y2.4%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRNL.AS Yearly Revenue VS EstimatesBRNL.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
BRNL.AS Yearly EPS VS EstimatesBRNL.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.53, which means the current valuation is very expensive for BRNL.
The rest of the industry has a similar Price/Earnings ratio as BRNL.
Compared to an average S&P500 Price/Earnings ratio of 27.67, BRNL is valued at the same level.
With a Price/Forward Earnings ratio of 10.89, the valuation of BRNL can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRNL indicates a somewhat cheap valuation: BRNL is cheaper than 78.13% of the companies listed in the same industry.
BRNL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.33.
Industry RankSector Rank
PE 26.53
Fwd PE 10.89
BRNL.AS Price Earnings VS Forward Price EarningsBRNL.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BRNL is valued a bit cheaper than the industry average as 78.13% of the companies are valued more expensively.
90.63% of the companies in the same industry are more expensive than BRNL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.46
EV/EBITDA 7.4
BRNL.AS Per share dataBRNL.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.52
EPS Next 2Y2.29%
EPS Next 3Y6.75%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.90%, BRNL is a good candidate for dividend investing.
BRNL's Dividend Yield is rather good when compared to the industry average which is at 3.26. BRNL pays more dividend than 93.75% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, BRNL pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.9%

5.2 History

On average, the dividend of BRNL grows each year by 17.14%, which is quite nice.
Dividend Growth(5Y)17.14%
Div Incr Years0
Div Non Decr Years6
BRNL.AS Yearly Dividends per shareBRNL.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

182.53% of the earnings are spent on dividend by BRNL. This is not a sustainable payout ratio.
The dividend of BRNL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP182.53%
EPS Next 2Y2.29%
EPS Next 3Y6.75%
BRNL.AS Yearly Income VS Free CF VS DividendBRNL.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M
BRNL.AS Dividend Payout.BRNL.AS Dividend Payout, showing the Payout Ratio.BRNL.AS Dividend Payout.PayoutRetained Earnings

BRUNEL INTERNATIONAL

AMS:BRNL (10/24/2025, 11:57:17 AM)

7.96

-0.04 (-0.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-01 2025-08-01
Earnings (Next)11-07 2025-11-07
Inst Owners10.8%
Inst Owner ChangeN/A
Ins Owners65.39%
Ins Owner ChangeN/A
Market Cap402.54M
Revenue(TTM)1.28B
Net Income(TTM)15.20M
Analysts80
Price Target10.37 (30.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.9%
Yearly Dividend0.55
Dividend Growth(5Y)17.14%
DP182.53%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.45%
EPS NY rev (3m)-30.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.63%
Valuation
Industry RankSector Rank
PE 26.53
Fwd PE 10.89
P/S 0.31
P/FCF 6.46
P/OCF 5.48
P/B 1.49
P/tB 2.04
EV/EBITDA 7.4
EPS(TTM)0.3
EY3.77%
EPS(NY)0.73
Fwd EY9.18%
FCF(TTM)1.23
FCFY15.49%
OCF(TTM)1.45
OCFY18.25%
SpS25.36
BVpS5.34
TBVpS3.9
PEG (NY)N/A
PEG (5Y)0.52
Graham Number6
Profitability
Industry RankSector Rank
ROA 2.79%
ROE 5.63%
ROCE 9.04%
ROIC 5.99%
ROICexc 7.41%
ROICexgc 9.6%
OM 2.77%
PM (TTM) 1.19%
GM 18.53%
FCFM 4.86%
ROA(3y)5.23%
ROA(5y)5.1%
ROE(3y)9.87%
ROE(5y)9.22%
ROIC(3y)9.07%
ROIC(5y)8.49%
ROICexc(3y)11.74%
ROICexc(5y)11.8%
ROICexgc(3y)14.99%
ROICexgc(5y)14.77%
ROCE(3y)13.69%
ROCE(5y)12.82%
ROICexgc growth 3Y-2.66%
ROICexgc growth 5Y20.96%
ROICexc growth 3Y-2.76%
ROICexc growth 5Y16.65%
OM growth 3Y-10.31%
OM growth 5Y16.91%
PM growth 3Y-14.07%
PM growth 5Y42.87%
GM growth 3Y-6.27%
GM growth 5Y-0.85%
F-Score5
Asset Turnover2.36
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 1.94
Debt/EBITDA 1.79
Cap/Depr 43.99%
Cap/Sales 0.87%
Interest Coverage 7.12
Cash Conversion 120.85%
Profit Quality 410.12%
Current Ratio 2.71
Quick Ratio 2.71
Altman-Z 4.5
F-Score5
WACC6.67%
ROIC/WACC0.9
Cap/Depr(3y)50.13%
Cap/Depr(5y)44.09%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.46%
EPS 3Y-1.22%
EPS 5Y50.91%
EPS Q2Q%-97.98%
EPS Next Y-27.98%
EPS Next 2Y2.29%
EPS Next 3Y6.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y14.9%
Revenue growth 5Y5.56%
Sales Q2Q%-11.33%
Revenue Next Year-6.3%
Revenue Next 2Y-0.35%
Revenue Next 3Y2.4%
Revenue Next 5YN/A
EBIT growth 1Y-34.97%
EBIT growth 3Y3.05%
EBIT growth 5Y23.41%
EBIT Next Year20.25%
EBIT Next 3Y18.19%
EBIT Next 5YN/A
FCF growth 1Y2564.74%
FCF growth 3Y103.74%
FCF growth 5Y44.93%
OCF growth 1Y392.18%
OCF growth 3Y78.93%
OCF growth 5Y36.77%